OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that Eric Johnson, Ph.D. has joined the company as Medical Director for Laboratory Services. In this newly created position Dr. Johnson will be responsible for leading the strategic vision and managing the day-to-day operations of Transgenomic’s Molecular Diagnostics Services lab. Dr. Johnson brings to Transgenomic nearly […]
NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to Seegene (KOSDAQ; Korea Securities Dealers Automated Quotations). In addition, Biosearch will manufacture both research and IVD grade […]
BlueGnome announced today that it has completed the acquisition of the intellectual property for Karyomapping – a powerful new approach for pre-implantation genetic diagnosis (PGD). PGD is used, in combination with IVF approaches, where there is a risk of severe genetic disorders being inherited from parents. PGD screening is used to identify embryos that do […]
Universal Sensors to take innovation to product with SBRI contract Universal Sensors is rising to the challenge of creating a hand-held device – able to detect the presence of C.difficile or MRSA in hospital wards within 5 minutes of swabbing – following the success of its initial project. The company, which designs and manufactures sensitive, […]
Dortmund – Dortmund based Protagen AG, a specialist in in-vitro diagnostics and GMP-conform protein analytics and MicroDiscovery GmbH, a bioinformatics company based in Berlin, have started a cooperation to identify and validate biomarkers for medically relevant diseases. “Our proprietary technology platform UNIarray® and MicroDiscovery’s certified software solutions for the analysis of complex marker panels complement […]
New solution combines multiplexing and automation technologies to create novel system that provides faster results and saves valuable time and resources in newborn screening laboratories Männedorf, Switzerland, and Austin, Texas – The Tecan Group (SIX Swiss Exchange: TECN) and Luminex Corporation (NASDAQ: LMNX) have announced that they will collaborate on the development of a new […]
UK-based molecular diagnostics company Biofortuna Limited has unveiled the world’s first complete freeze-dried HLA PCR kit in a move set to transform the transplantation market. The award-winning firm, led by internationally renowned HLA molecular immunologist Dr Mike Bunce, is revolutionising clinical testing methods with its proprietary freeze-dried ‘SSP Go’ technology. SSP Go is a novel […]
Company optimistic about pilot data and embarks on rigorous clinical study Denver, CO, USA – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has presented potentially highly significant, preliminary data on the development of a panel of biomarkers for the diagnosis of prostate cancer. In the pilot […]
Protagen AG, a specialist for GMPcompliant protein analysis and in-vitro diagnostics is presenting at the Biotechnica conference 2010 in Hanover. The experts of the company will provide insights into the latest developments of GMP-compliant protein analysis and applications of the UNIarray® technology platform. UNIarray® serves as a unique technology platform to develop and validate novel, […]
NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has been awarded a Phase II Small Business Innovative Research (SBIR) grant from the Department of Defense (DoD). The purpose of the $800,000+ Phase II grant is to continue […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
